Sun Pharmaceutical vs Divis Laboratories
Both trade above their peers' median P/E; Sun Pharmaceutical Industries by less (3% above, against 115% above for Divis Laboratories).
Divis Laboratories earns the higher return on equity: 16.5% against 12.7%.
Sun Pharmaceutical Industries grew revenue faster over three years: 11.5% a year against 10.9% a year.
Divis Laboratories fires fewer of our forensic red flags: 1 of 30 judged against 2 of 30 judged.
The latest change on file is Divis Laboratories', on 7 Nov 2026: Q2 FY2027 results filed.
Sun Pharmaceutical Industries trades at a P/E of 41.90: 10th of 16 among its peers (peer median 40.8).
Sun Pharmaceutical Industries: the full company page →Divis Laboratories trades at a P/E of 87.56: 9th of 10 among its peers (peer median 40.8).
Divis Laboratories: the full company page →Sun Pharmaceutical Industries and Divis Laboratories, figure by figure
| Figure | Sun Pharmaceutical | Divis Laboratories | Leads |
|---|---|---|---|
| Market cap | ₹4,59,473 Cr | ₹2,94,590 Cr | Sun Pharmaceutical Industries, larger |
| P/E | 41.90 | 87.56 | Sun Pharmaceutical Industries, cheaper |
| P/B | 18.85 | 9.43 | Divis Laboratories, cheaper |
| Dividend yield | 0.9% | 0.3% | Sun Pharmaceutical Industries, higher |
| ROE | 12.7% | 16.5% | Divis Laboratories, higher |
| ROCE | 14.5% | 21.4% | Divis Laboratories, higher |
| Profit margin | 17.2% | 26.7% | Divis Laboratories, higher |
| Revenue growth, 3 years | 11.5% a year | 10.9% a year | Sun Pharmaceutical Industries, faster |
| Profit growth, 3 years | 10.7% a year | 12.1% a year | Divis Laboratories, faster |
| 1-year return | +12.8% | +65.8% | Divis Laboratories, higher |
| 5-year return | +17.5% a year | +13.7% a year | Sun Pharmaceutical Industries, higher |
| Quality score | 47.8 | 64.8 | Divis Laboratories, higher |
| Our valuation view | Fair, low confidence (held for review) | Dear, low confidence (held for review) | Sun Pharmaceutical Industries, cheaper view |
| Risk level | WATCH | WATCH | Level |
| Forensic red flags | 2 red of 30 judged | 1 red of 30 judged | Divis Laboratories, fewer |
The leading figure is in green: the lower for P/E, P/B, cost to income, NPAs, risk and red flags, the higher for the rest. P/E and P/B on the latest price; growth rates are yearly averages; returns are price only. Our valuation view and the red flags are explained on each company's page.
Which is bigger, Sun Pharmaceutical Industries or Divis Laboratories?
Sun Pharmaceutical Industries is the bigger company by market value: ₹4,59,473 Cr against ₹2,94,590 Cr for Divis Laboratories, about 1.6 times as large.
Sun Pharmaceutical Industries market cap is ₹4,59,473 crore (large cap), making it the 14th largest listed company on the NSE.
Divis Laboratories market cap is ₹2,94,590 crore (large cap), making it the 32nd largest listed company on the NSE.
Which is cheaper on valuation, Sun Pharmaceutical Industries or Divis Laboratories?
Sun Pharmaceutical Industries is the cheaper of the two on P/E: 41.90 against 87.56 for Divis Laboratories.
On price to book, Divis Laboratories is the cheaper: 9.43 against 18.85.
Against their own peers' median P/E, Sun Pharmaceutical Industries trades 3% above its own (40.8) and Divis Laboratories trades 115% above its own (40.8).
Our valuation view: fair on Sun Pharmaceutical Industries (low confidence) and dear on Divis Laboratories (low confidence). The view weighs the multiples against each company's peers and its own history.
Which is more profitable, Sun Pharmaceutical Industries or Divis Laboratories?
Divis Laboratories is the more profitable on return on equity: 16.5% against 12.7% for Sun Pharmaceutical Industries.
ROCE: Divis Laboratories 21.4%, Sun Pharmaceutical Industries 14.5%.
Profit margin: Divis Laboratories 26.7%, Sun Pharmaceutical Industries 17.2%.
Which grew faster, Sun Pharmaceutical Industries or Divis Laboratories?
Sun Pharmaceutical Industries grew faster over the last three years: revenue up 11.5% a year against 10.9% a year for Divis Laboratories.
Profit growth, 3 years: Divis Laboratories 12.1% a year, Sun Pharmaceutical Industries 10.7% a year.
Which has cleaner accounts, Sun Pharmaceutical Industries or Divis Laboratories?
Divis Laboratories has the cleaner accounts on our forensic checks: 1 red flag of 30 judged against 2 of 30 judged for Sun Pharmaceutical Industries.
Sun Pharmaceutical Industries: risk level WATCH, 30 of 30 flags judged.
Divis Laboratories: risk level WATCH, 30 of 30 flags judged.
A red flag is a figure out of line with what clean accounts show, not a finding of wrongdoing.
What these figures tell you
More comparisons
What this page rests on
Every figure is the one Sun Pharmaceutical Industries' and Divis Laboratories' own pages print, from their filings with the exchanges and our arithmetic on them; each company is set against its own peer set. A side-by-side reading of the figures on both company pages, not a recommendation to buy, sell or hold either share. Which figure matters more depends on what you are looking for.